跳至主要内容
临床试验/NCT00455832
NCT00455832已完成不适用

Influence of Ribavirin and Interferon on Semen Quality, IRIS Study

Foundation for Liver Research1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2006年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
23
试验地点
1

研究概览

简要总结

The aim of this study is to study the effect of peginterferon alpha and ribavirin on spermatozoa.

详细描述

During and six months after treatment with peginterferon alpha and ribavirin strict use of birth control is recommended (the producers advice two reliable forms) for both men and women because ribavirin has teratogenic and/or embryo-lethal effects in animal studies.

In cases of pregnancies during paternal exposure to peginterferon alpha and ribavirin elective termination of the pregnancy is usually recommended. However three cases of births after paternal exposure are reported with no birth defects. Cases of abnormalities after paternal exposure to ribavirin are lacking.

Also studies on the influence of ribavirin on sperm in human are lacking.

The aim of this study is to study the effect of peginterferon alpha and ribavirin on spermatozoa in men using these medication.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Written informed consent
  • Treatment with peginterferon and ribavirin in the presence of a chronic Hepatitis C infection

排除标准

  • Preexisting semen abnormalities.
  • Concurrent use of drugs influencing sperm concentration,motility and morphology.
  • Less then one million spermatozoa/ml in semen at screening.

研究者

发起方
Foundation for Liver Research
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验